Literature DB >> 14801772

Arrhenoblastoma; the incidence of malignancy and the relationship to pregnancy, to sterility, and to treatment.

C T JAVERT, W F FINN.   

Abstract

Entities:  

Keywords:  OVARY; PREGNANCY; STERILITY; TUMORS, ARRHENOBLASTOMA

Mesh：

Year:  1951        PMID： 14801772     DOI： 10.1002/1097-0142(195101)4:1<60::aid-cncr2820040106>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  [Arrhenoblastoma and pregnancy].

Authors:  H SIMMER; H G HILLEMANNS
Journal:  Arch Gynakol       Date:  1962

2.  [Clinical, histological and histochemical observations on an arrhenoblastoma].

Authors:  H A KRONE; W KUEBLER
Journal:  Arch Gynakol       Date:  1961

3.  Metabolic disturbances in disseminated neoplastic disease.

Authors:  W P L MYERS
Journal:  Bull N Y Acad Med       Date:  1957-10

4.  Sertoli and Leydig cells in relation to ovarian tumours.

Authors:  F A LANGLEY
Journal:  J Clin Pathol       Date:  1954-02       Impact factor: 3.411

5.  Masculinizing tumors of the ovary.

Authors:  V E Aimakhu; J A Adeleye; M Hendrickse; J P de Von Hendrickse; G Iloabachie
Journal:  J Natl Med Assoc       Date:  1976-01       Impact factor: 1.798

6.  Pure and mixed hilus-cell tumours of ovary. Arris and Gale Lecture delivered at the Royal College of Surgeons of England on 14th November 1966.

Authors:  R Salm
Journal:  Ann R Coll Surg Engl       Date:  1967-10       Impact factor: 1.891

7.  Intersexual states and allied conditions.

Authors:  P M Bishop
Journal:  Br Med J       Date:  1966-05-21

8.  Ovarian Sertoli-Leydig cell tumors. A clinical, pathological and ultrastructural study with particular reference to the histogenesis of these tumors.

Authors:  C Y Genton
Journal:  Arch Gynecol       Date:  1980

9.  The hormone pattern in a case of arrhenoblastoma.

Authors:  V Toscano; M V Adamo; B Boscherini; A M Pasquino; L Herlitzka; E Petrangeli; F Sciarra
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.